Literature DB >> 7521163

Extracellular ATP potentiates nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages.

M Tonetti1, L Sturla, T Bistolfi, U Benatti, A De Flora.   

Abstract

Inducible nitric oxide synthase (iNOS) activity in the murine macrophage cell line RAW 264.7 was increased from two- to four-fold after co-exposure of the cells to low doses of bacterial lipopolysaccharide (LPS) and micromolar ATP, compared to LPS alone. Extracellular ATP and its analogs "per se", i.e. without LPS, were not able to induce iNOS activity. The stimulating effect of UTP too, the concentration range of activity (1-100 mM nucleotides) and the rank of potency (ATP-gamma-S = AMP-PNP > ATP = ADP >> AMP-CPP = UTP) seem to indicate an involvement of P2y-type purinergic receptors. GTP, CTP and adenosine were virtually ineffective. These data suggest that binding of extracellular nucleotides to purinergic receptors may increase nitric oxide production by macrophages. This effect might occur in pathological conditions (i.e. inflammation/infection or trauma) where significant amounts of intracellular ATP can be released due to cellular damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521163     DOI: 10.1006/bbrc.1994.2200

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  P2 receptors: intracellular signaling.

Authors:  Laurie Erb; Zhongji Liao; Cheikh I Seye; Gary A Weisman
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

2.  Acute paw oedema formation induced by ATP: re-evaluation of the mechanisms involved.

Authors:  L E Ziganshina; A U Ziganshin; C H Hoyle; G Burnstock
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

3.  Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.

Authors:  Otgonchimeg Rentsendorj; Franco R D'Alessio; David B Pearse
Journal:  J Leukoc Biol       Date:  2014-07-25       Impact factor: 4.962

Review 4.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

Review 5.  P2 receptors: new potential players in atherosclerosis.

Authors:  Francesco Di Virgilio; Anna Solini
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

6.  ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages.

Authors:  G Haskó; D G Kuhel; A L Salzman; C Szabó
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

7.  Pyrimidinoceptor potentiation of macrophage PGE(2) release involved in the induction of nitric oxide synthase.

Authors:  B C Chen; W W Lin
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

8.  P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Pieter-Jan D F Guns; Jan Hendrickx; Tim Van Assche; Paul Fransen; Hidde Bult
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

9.  Cell signaling via the P2X(7) nucleotide receptor: linkage to ROS production, gene transcription, and receptor trafficking.

Authors:  Lisa Y Lenertz; Monica L Gavala; Lindsay M Hill; Paul J Bertics
Journal:  Purinergic Signal       Date:  2009-03-05       Impact factor: 3.765

10.  Evidence that hsp90 is involved in the altered interactions of Acanthamoeba castellanii variants with bacteria.

Authors:  Ling Yan; Ronald L Cerny; Jeffrey D Cirillo
Journal:  Eukaryot Cell       Date:  2004-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.